3SOF

Stock Picking Contest (4th Edition - From 6/March/2006 to 10/Apr/2006)

To Submit your Stock Pick, reply to this Topic following the Standard Layout:

1)   Stock Pick
(Ticker & Name of the Company)

2)   Reason behind this pick
(a Text with at least 50 words, featuring the reasons of your stock pick)

3)   Stock Chart
(Click in additional options, browse for your chart file GIF/JPG/PNG and add it to your post, if you don't have a Charting software, we suggest you copy a chart from www.stockcharts.com)

Important: Do not use this thread to another purpose rather than submitting your stock pick. For organizational purposes, any reply that is not a stock pick will be deleted.

My Pick:

HOM (Home solutions of America)


Hom is set to report earnings and if indications are correct it will be al good for HOM. They raised guidance for '06 several times last year and there hasn't been any negative news. They have been hush hush lately and the stock is beginning to move. That tells me that the earnings report is going to be a good one and the stock will move up further. I'm hoping for a price in the high 7s for march. If that happens I should do pretty good in the contest. I also own HOM in my portfolio incase anybody wonders.

(//)

My Pick:

NNSR  Nanosensor Inc

Company looks very promosing!! Looks to be very oversold as of 2/22 for no reason at all, should return to previous range of .33 to .45 soon and then move up from there. If you notice a bullish harami formed on 2/24 but the white candlestick was to long, thus the reliabiity for a reversal was lowered, I suspect a bullish morning star is forming as of 3/1 then this would be a true reversal and would be a strong indication of an uptrend.

1)   GIGM - GIGAMEDIA LTD (NasdaqNM:GIGM)

2)   Former 3SOF Short Term portfolio pick that produced a 65% return.  Current 3SOF Long Term portfolio pick.  The stock has a good base at $4.50 put in and has been consolidating around this base for about 2 weeks.  I believe they will announce Q4 results during the time frame of this contest and provide quidence for '06 which will include results from their recent Fun Town aquisition.  I believe this will provide a catalyst to move the stock out of the base.  This pick of GIGM in this edition of the contest may just become a case of "the right place, at the right time".  My only hope is that any move in this stock not happen until after this contest begins.  Hee heee

3)   Stock Chart

NVAX - Novavax Inc.

This stock is widely followed on this board. NVAX is one of many companies that are planning on creating a vaccine for use in case of a bird flu pandemic. Few days ago Kleiner Perkins invested $12.5 million in the company. Kleiner Perkins has a track record of investing in companies with great potential. Some of their early investments were in companies like Google, AOL, Amazon.com, Netscape etc. With additional funding coming from Congress in the near future, I think NVAX will be one of the beneficiaries.

My picks in these comps so far have sucked big time ;) So here comes another kiss of death....

1) eDiets DIET

2) Company is undervalued relative to opportunity. This year they introduced a new food delivery progam (as widely discussed in this community, e.g 1reilly experiment) called Fresh Cuisine. Whilst this introduction will have no bearing in current financials, the guidance and update on it will. The chart is hovering close to all time highs with support from moving averages close by. Any half decent news on Fresh Cuisine success and opportunity  will move this through the $8 barrier for good.

3) Chart

My pick :

1) Sciclone Pharma(scln)

SciClone Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutics to treat life-threatening diseases. Its products include ZADAXIN is in phase 3 hepatitis C virus clinical trials, as well as in other late-stage clinical trials for the treatment of hepatitis B virus and certain cancers. The company also develops SCV-07, which is in preclinical studies, for the treatment of viral and other infectious diseases. The company sells its products primarily in Asia, the Middle East, and Latin America. SciClone Pharmaceuticals was founded in 1989 and is headquartered in San Mateo, California


I played this one around 5-6 range before it got hit hard in Dec'05 due to their lackluster phase III results of their core product  ZADAXIN . The recent Q4 results show that they have great demad for ZADAXIN in china and 91% of their sales from the drug is from china.
Also, insider are buying.

Press Release Source: SciClone Pharmaceuticals, Inc.


SciClone Reports Results for Fourth Quarter and Year-End 2005
Wednesday March 1, 6:30 am ET


SAN MATEO, CA--(MARKET WIRE)--Mar 1, 2006 -- SciClone Pharmaceuticals, Inc. (NasdaqNM:SCLN - News) today reported results for the fourth quarter and full year ended December 31, 2005. For the fourth quarter 2005, revenues from the sale of ZADAXIN®, SciClone's lead product, increased by 22% to $7,314,000, compared with revenues of $5,985,000 reported for the fourth quarter 2004. For the full year ended December 31, 2005, product revenues increased by 22% to $27,842,000, compared with product revenues of $22,765,000 for 2004. The increase in product revenues for the fourth quarter and year ended December 31, 2005 is primarily attributable to an increase in the quantity of ZADAXIN sold to the China market, which accounts for approximately 91% of overall ZADAXIN sales.
ADVERTISEMENT


Net loss for the fourth quarter 2005 totaled $1,625,000, or $0.04 per share, a decrease of 30% from the net loss of $2,355,000, or $0.05 per share, for the fourth quarter 2004. For the full year ended December 31, 2005, net loss was $7,713,000, or $0.17 per share, a 42% decrease from the net loss of $13,278,000, or $0.30 per share, for the full year ended December 31, 2004.

"We are pleased with the increasing trend in sales of ZADAXIN to China, a market where ZADAXIN is approved for hepatitis B and is used extensively in the oncology and intensive care settings," said Ira D. Lawrence, M.D., President and Chief Executive Officer of SciClone Pharmaceuticals, Inc. "As we continue in 2006, we intend to build on our strong reputation in China by devoting additional resources to expand our product offerings and our development and regulatory capabilities in that market. At the same time, we continue to advance our clinical pipeline. We expect additional ZADAXIN melanoma results later this year and we expect to meet with regulatory authorities to finalize plans for phase 3 trials. In addition, we plan to initiate a phase 1 study evaluating oral formulations of SCV-07 in the second quarter of this year and to begin phase 2a studies for SCV-07 starting in the second half of this year."

Contract revenue for the fourth quarter 2005 was $90,000 compared with $134,000 for the fourth quarter 2004. For the full year ended December 31, 2005, contract revenue totaled $492,000, compared with $1,631,000 for the full year ended December 31, 2004. Contract revenue for the full year ended December 31, 2004 included a $1,000,000 milestone payment from Sigma-Tau, SciClone's European marketing and development partner for ZADAXIN.

Research and development expenses for the fourth quarter 2005 totaled $3,213,000, a 28% decrease from $4,442,000 for the fourth quarter 2004. Research and development expenses for the full year ended December 31, 2005 were $14,406,000, a 20% decrease from $17,994,000 for the full year ended December 31, 2004. These decreases are mainly attributable to the reduction in expenses associated with SciClone's U.S. phase 3 hepatitis C trials.

General and administrative (G&A) expenses for the fourth quarter 2005 were $1,944,000, a 51% increase from $1,289,000 for the fourth quarter 2004. G&A expenses for the full year 2005 were $7,457,000, an 18% increase from $6,311,000 for the full year 2004. The increase in the fourth quarter 2005 was due to higher salary expenses, increased legal costs and accounting fees, and a reversal of a bad debt expense of $186,000 that lowered G&A expenses in the fourth quarter of 2004. The increase in G&A expenses for 2005 are primarily attributed to increased legal costs, and accounting fees, and the expensing of stock price-based options.

Cash, cash equivalents and short-term investments totaled $42,256,000 at December 31, 2005, compared with $49,524,000 at September 30, 2005 and $51,299,000 at December 31, 2004. Part of the decrease in cash, cash equivalents and short-term investments is attributable to the repayment of a $4 million convertible note in December 2005.

Financial Guidance for Full Year 2006

Based on SciClone's current plans for operations and clinical development, the Company estimates that revenues from the sale of ZADAXIN for the full year 2006 will increase to approximately $32,000,000 driven primarily by continued growth in sales to China. Research and development expenses for the full year 2006 are estimated to be approximately $14,000,000 as new programs are advanced as described above and below. Net loss for the full year 2006 is estimated to be approximately $6,100,000, or $0.13 net loss per share.

In January 2006, the Company adopted Financial Accounting Standards Board Statement No.123 (revised 2004), "Share-Based Payment" (SFAS 123R) requiring share-based payments to employees and directors, including grants of stock options, to be recognized in statement of operations based on their fair values. Including SFAS 123R related charges, the Company estimates research and development expenses for the full year 2006 to be appoximately $14,800,000, and net loss for the full year 2006 to be approximately $8,900,000, or $0.19 net loss per share. SFAS 123R related expenses will be non-cash charges.

Cash, cash equivalents and short-term investments at year-end 2006 are estimated to be approximately $29,000,000 including the repayment of $1,600,000 of convertible notes in March 2006.

Recent Clinical Development Highlights

SciClone recently completed phase 1 single and multi-dose escalation studies and achieved positive results demonstrating that SCV-07, its second drug candidate, appears to be safe and well tolerated in healthy volunteers. SCV-07 was administered subcutaneously in varying dose levels up to a dose of 1 mg/kg, approximately one thousand times the dose level utilized in a proof-of-concept tuberculosis trial in Russia, without any dose-limiting adverse effects.

Based on promising data from pre-clinical studies that demonstrated the oral bioavailability of SCV-07 in an animal model, SciClone plans to initiate a phase 1 clinical trial evaluating two oral formulations of SCV-07 in healthy volunteers in the second quarter of 2006. If this study yields favorable results, SciClone believes that the availability of an oral formulation of SCV-07 would considerably broaden the development opportunities for SCV-07. Additionally, based on pre-clinical data that suggest SCV-07's utility in a variety of clinical settings including viral and infectious diseases, SciClone intends to initiate phase 2a studies with the subcutaneous formulation of SCV-07 starting in the second half of this year.

Update on Mediation with Schering Plough KK (SPKK)

As part of the mediation process, SciClone and SPKK have exchanged and are exchanging certain information and are discussing issues for resolution. The mediation is expected to conclude by the end of March 2006. Should SciClone and SPKK be unable to come to a mutually satisfactory and fair resolution by the end of the mediation, it is expected that binding arbitration would commence soon thereafter.

Conference Call

SciClone will host a conference call at 11:30 a.m. ET (8:30 a.m. PT) today, Wednesday, March 1, 2006. The call will contain forward-looking statements. Financial and statistical information to be discussed in the conference call will be posted on the investor relations section of SciClone's web site at www.sciclone.com prior to the commencement of the conference call.


DATE:       Wednesday, March 1, 2006


1) Chart

1) BNT
Bentley Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. It focuses on developing, licensing, and sale of generic and branded pharmaceutical products and active pharmaceutical ingredients, and the manufacturing of pharmaceuticals for others; and research, development, and licensing/commercialization of advanced drug delivery technologies and pharmaceutical products. Bentley pharmaceuticals manufactures and markets approximately 120 pharmaceutical products for various dosage strengths and product formulations of approximately 30 chemical entities in four primary therapeutic areas: cardiovascular, gastrointestinal, neurological, and infectious diseases; as well as markets over-the-counter products.

2)
BNT Citigroup Healthcare Conference Presentation (33slides):
http://www.veracast.com/webcasts/citigroup/healthcare06/45303595.cfm

3)
Latest news:
Bentley announces score of Spanish generics approvals
Tuesday , February 28, 2006 11:18 ET
Feb 28, 2006 (Datamonitor via COMTEX) -- Bentley Pharmaceuticals saw its shares rise by around 6% after announcing that it had received 12 marketing approvals in Spain for its generic versions of Forest Laboratories' Celexa, Merck & Co's Proscar and Bristol-Myers Squibb's Pravachol. Bentley received approval to market a 30mg generic version of depression drug Celexa (citalopram) in Spain through its wholly-owned subsidiaries, Laboratorios Rimafar and Laboratorios Davur, and a branded-generic version of the 30mg dosage level of citalopram through its Laboratorios Belmac subsidiary. The branded version is marketed under the Belmac trade name Somac. Bentley also received approval to market a 5mg generic version of Proscar (finasteride) in Spain through Belmac, Davur and Rimafar. Finasteride belongs to a class of type II 5 alpha-reductase inhibitors used in the treatment of enlarged prostate glands. In addition, Laboratorios Rimafar and Laboratorios Belmac each received approvals to market generic-equivalent and branded versions of pravastatin in 10mg, 20mg and 40mg tablets.
Finally, Bentley received approvals for a generic version of heart drug Pravachol (pravastatin) in 10mg, 20mg, 40mg and 80mg dosage levels, for which Laboratorios Davur gained marketing rights in October 2005. "These approvals strengthen our portfolio and underscore our success in advancing our pipeline, both in Spain and in other European countries," noted John Sedor, Bentley's president. "These latest approvals follow the 51 we received over the past 12 months, including 30 approvals in Spain and 21 in other EU countries."

4) Major holders:
http://finance.yahoo.com/q/mh?s=BNT

5)
Always discussed in detail with Michael in his BNT board:
http://www.3stocksonfire.org/trading/index.php?topic=621.new#new

6)
CC on March 8th will be positive, shorts will be squeezed:

BNT: Short Interest UP 33.7% to 2.9M in Feb 2006
Wednesday, February 22, 2006 17:46 ET
According to new short interest data from NYSE, short interest for Bentley Pharmaceuticals, Inc. (NYSE: BNT) INCREASED 33.7% to 2,892,167 shares for the month ended mid-February, 2006.

SYMBOL      JANUARY        FEBRUARY          CHANGE       %CHANGE    DAYS/COVER
--------   -------------   -------------   -------------  ------------  ----------
BNT            2,162,869       2,892,167        +729,298       +33.72%           5

Based on BNT's 20-day average daily share volume of 614,425, it would require approximately 5 day(s) of buying to cover this short interest.

charts & additional infos:

Ivan Again.
        Tons of good setups this time around that I had a very hard time trying to decide.  Many of them on my radar forever.  I picked Ivan last time based on it's volume/price spike and filled at 2.79.  Other reasons were their heavy to light oil technology, their presence in Calif. and China.  Since then the Calif. deep well kinda took a crapo.  But, on the other hand they have seemed to consolidate their position in China. 
         I "feel" oil in general is going to have a blow out rise through the next month due to international tensions, ending sometime during first part of April with buying capitulation.  Then slide into the northern hemisphere driving/industrial season (don't want to get all the consumers too upset).
         Technically Ivan has had a golden cross of late, macd seems to be going positive, and the rsi has room to rise.  I'm particularly glad that there wasn't a strong gain on Friday ( though it appeared there would be), traders abandoned it late day.  If they hadn't brought it down I would have made a different pick.   This bodes well for a good fill on Monday morning.  I anticipate that the speculation will come back next week. 
         So I'm stickin with it, thinkin' that with a little more time the same pick should make it's run.  Any close above today's will be a positive sign and give a target of 3.19.  Any close above that, well then ::), 4.25 would be the sell target.  Today's close is the highest in more than a year.  So if you are holding Ivan, sell it before the open so I can get a good fill.  I have no funds, only fun on this one.

MBAY

Something is going on with 4 days huge volume. Float is only 8.93M (from Yahoo).

mbay

the relevant news is this:

"TUESDAY, FEBRUARY 07, 2006 8:31 AM
Feb 07, 2006 /PRNewswire-FirstCall via COMTEX/ -- MediaBay, Inc. (MBAY) today announced that in an effort to maximize shareholder value and further capitalize on the company's proprietary content and evolving digital distribution business, MediaBay has retained MediaTech Capital Partners to assist the company in reviewing and possibly executing a variety of strategic options available to the company."

Last 4 days mbay doubled with enormous volume.....maybe someone "knows"
sma 100 is gone.....next step sma 200, jmho

don't forget
Total Cash Per Share (mrq): 0.993

TGB  Taseko Mines Ltd
Engaged in gold and copper mining .. I expect production numbers to increase for the company especially in Copper and the prices of both metals prices to continue move up in the short term..

chart below

http://stockcharts.com/def/servlet/SC.web?c=tgb,uu[w,a]daclyyay[de][pb50!b200][vc60][iUc20!Lya7,14,28]&pref=G

Stock Picking Contest (4th Edition - From 6/March/2006 to 10/Apr/2006)

To Submit your Stock Pick, reply to this Topic following the Standard Layout:

1)   Stock Pick
My pick is AZK.  AURIZON MINES LTD

2)   Reason behind this pick
(a Text with at least 50 words, featuring the reasons of your stock pick)
Company Summary: Aurizon Mines, Ltd. operates as a gold mining company with operations, development, and exploration activities in the gold producing Abitibi region of north-western Quebec. It owns a 100% interest in the Casa Berardi property located approximately 95 kilometer north of the town La Sarre in the province of Quebec. The company was incorporated as 343318 B.C., Ltd. in April 1988 and changed its name to Aurizon Mines, Ltd. in August 1988. Aurizon Mines is headquartered in Vancouver, Canada.
The company is involved in gold mining and has an upcoming mine in next quarter which will provide it lot of gold with profitable streak.
Last news:
"Aurizon management are very optimistic that gold prices will continue to rise," said Ian Walton, Aurizon's CFO. "However, it is prudent for us to protect any potential downside in the price of gold from unforeseen market forces. The program that we have implemented provides protection that future operating cash flows are available to service the project debt, should gold prices decline, without giving away the Company's participation in the upside potential for gold and the Project."
Casa Berardi continues to progress on budget, on schedule and to design specification. The production shaft at the West Mine is currently at a depth of 500 metres and the ramp has reached the 690 metre level. On surface, the headframe, hoist room and associated infrastructures are complete, while major components of the mill refurbishing and modifications are in progress. More than 300 people are currently active on site. The project is currently expected to produce 1,092,000 ounces from 4.8 million tonnes of ore over the initial 6.2 year operating plan, based on current mineral reserves. Additional resources comprise 2.7 million tonnes of indicated resources with an average grade of 5.1 grams of gold per tonne and 5.6 million tonnes of inferred resources averaging 6.5 grams of gold per tonne. Drilling activities are on-going with three underground drill rigs and four surface drill rigs currently in operation.
Commercial production at Casa Berardi is expected to commence in the fourth quarter of this year at an average rate of 175,000 ounces of gold per annum. At a gold price of US$550 per ounce, and an exchange rate of 1.15, the project would have an estimated total cash cost of US$240 per ounce, an internal rate of return of 47% and an estimated payback of approximately 2 years.
AZK trades above a $1.00 and more than av volume of  200K.


The momentum is built-in as you can see from the charts below.

3)   Stock Chart
(Click in additional options, browse for your chart file GIF/JPG/PNG and add it to your post, if you don't have a Charting software, we suggest you copy a chart from www.stockcharts.com)

Ternium S.A. (NYSE: TX [ADR])

Ternium is a Luxembourg-based steel producer which operates in Argentina, Venezuela and Mexico,  this allow them to trade within ALCA. MERCOSUR & others

Tips..

Starting February 1, 2006 Ternium SA began trading in the New York Stock Exchange (NYSE)

-Ternium's IPO priced @ $20 per ADS (now @ $23.95)

-Ternium's steel manufacturing and finishing facilities have an annual production capacity of about 11.6 million tons. The company sells its wares primarily to clients in North, Central, and South America, and it is developing a sales presence in Asia and Europe as well.

-Steel demand in our primary markets was strong in 2005, achieving growth rates above the world average, a pace that is expected to continue this year," according to the company statement. (01/03/2006)

The Pick: ANX - Adventrx Pharmaceuticals Inc.

More about the company
yahoo finance: http://finance.yahoo.com/q?s=ANX
company website:  http://www.adventrx.com

The reason:

I've been following the chart of ANX for a long time now... ever since I believe saffeysite(a great 3sof poster..not sure where he is?) brought it up.  He said something like doctors are talking about this stock and investing in it.. so that gave me enough interest to look at the chart.  I feel like there is a lot of power in ANX because of the kind of volume it has and the way the price acts.  A great uptrend as indicated by the 200sma(a slow ma) sloping up but I still believe its got some crazy pop in it...

I dont know a great deal about its business except that I like what they are doing.  Anti-Viral and Anti-Cancer research.  They seem to be doing well in "development" on these fronts so that could lead to huge price movement like CELG and DNA.

But what seems very interesting to me..as well as sneaky.. is that ANX is an avian flu play as well.  Check it out: http://biz.yahoo.com/prnews/060131/latu067a.html?.v=1

So I notice safety in the chart from the 50sma and the bullish trend.  I see ANX in a consolidation phase close to the big number 5.  So maybe it will breakout before the contest is over.  That breakout would be closing over 5... last March was the start of a great uptrend  >:D

Goodluck to everybody.  8)  Let the good times roll.

The Charts:

1) Stock Pick:
    HOMS  Homestore.Com Inc (NASDAQ: HOMS)

2) Reason behind the pick:
    Really nice chart. "I like , I love, I want some more of it!" ;D Nice looking move today.
    Good volume and price action. IMHO I think she is ready for more.
    Looks like it wants to Breakout..... Ascending Triangle.
    Strong volume on the upside. Stock did the correction off the high, it is now in solid         
    traction seeking new highs. Back above the 13-dma and also the 50-dma.
   
    Technicals
Record Price High
Record Price Break Out
Percentage Gainer

Last Price Quote is:
13.50%above 13-day EMA
inf%above 50-day EMA
RS Rating: 94 

Fundamentals
Key Data:
Market Cap (M): $923.66 
P/E Ratio: 256.06 
PEG Ratio: 3.98667 
Next Earnings: 05/11/2006
Last Analyst Rating: Mkt Perform

Give it a profile:

Homestore Inc.
30700 Russell Ranch Road
Westlake Village, CA 91362
Phone: 805-557-2300
Fax: 805-557-2680
Web Site: http://www.homestore.com

DETAILS   
Index Membership: N/A
Sector: Technology
Industry: Internet Information Providers
Full Time Employees: 1,456


BUSINESS SUMMARY   
Move, Inc., supplies online media and technology solutions for real estate industry professionals, advertisers, and providers of home and real estate-related products and services in North America. The company operates in three segments: Media Services, Software, and Print. The Media Services segment provides marketing and Web site solutions. This segment offers various services, such as classified advertising services that include enhanced listings, virtual tours, and online brochures; display advertising services that provide display advertising opportunities to individual real estate professionals; and directory listings that include directories of REALTORS, home builders, lenders, and self-service storage facilities. It also offers design and set-up of the Web sites, and hosting and maintenance services. The Software segment consists of Top Producer, which provides software solutions and related services to real estate professionals. Top Producer is the client management and marketing software specific to real estate agents. The Print segment comprises Welcome Wagon, which offers local and national merchants the opportunity to reach movers through targeted direct mail services; and Homestore Plans and Publications that offers consumers and building professionals to select new home designs and project plans from a range of home plans and project plans available. The company was incorporated as InfoTouch Corporation in 1993 and changed its name to Homestore.com, Inc. in 1999. Further, the company changed its name to Homestore, Inc. in 2002. It is now known as Move, Inc. The company is headquartered in Westlake Village, California.

1) EXFO (EXFO Electro Optical Engineering Inc)

2) While scanning some stocks today looking for ascending triangles I found EXFO. I haven't competed in this contest before and won't have tiime to scan stocks this weekend so I'll go with it. Strong breakout today from the 6.71 resistance. No resistance overhead. Plenty of volume with the breakout. Average volume is 102k so it just makes the requirements. Also bullish MACD with nice crossover. Analyst targets are between 5.50 and 8.00 with the majority issuing a buy rating.

Good luck to whoever chose MBAY as it was my first pick.  Hopefully SVA will be the eventual winner  >:D >:D

1)  SVA ---- SINOVAC BIOTECH LTD


2)  Sinovac has been hammered lately for the past few months.  I think it is time for a turnaround.  It has bounced off the support level established in June 05, AND there is a wolvewave pattern that has formed of late.  Based on this and the fact that they should have preliminary results of their clinical trials for bird flu vaccine due out in march should give rise to Sinovac's stock value for the coming month.

3)

1) Stock Pick:
    BGO:  Bema Gold Corp (AMEX: BGO)

2) Reason behind the pick:

    Although the stink DROOY mess me up big last contest, still get 10%+ profit in my real trading. You can not lose on trading gold stock under such kind of enviroment. This time I pick BGO in case gold going crazy again in the coming spring.

    The gold market has been drifting for the past few weeks as it consolidates its recent gains. After a brief flirt with the $535 support the gold price has rebounded back above $550 and ready to attack $570+ again, silver created 20-year new high this week. Oil refuse going down and Dollar looks weak recently. inflation is picking up again. I bet another bull run is here to come. don't get surprise if one day you get up, gold print $600 suddenly.

   BGO is resuming it's uptrend and continue outperforming $HUI index for weeks. who knows how high it will go?


(http://bigcharts.marketwatch.com/charts/big.chart?symb=bgo&compidx=aaaaa%3A0&ma=1&maval=20%2C50%2C200&uf=0&lf=268435456&lf2=0&lf3=0&type=4&size=2&state=8&sid=1248&style=320&time=10&freq=2&nosettings=1&rand=8635&mocktick=1)

SLW - Silver Wheaton

Description:

Silver Wheaton Corp. engages in the purchase and sale of silver. It purchases silver produced by Luismin mines in Mexico and the Zinkgruvan Mine in Sweden. The company was incorporated in 1994. It was formerly known as Chap Mercantile, Inc. and changed its name to Silver Wheaton Corp. in 2004. Silver Wheaton is headquartered in Vancouver, Canada.

Why They Are Hot:

VANCOUVER, British Columbia--(BUSINESS WIRE)--Feb. 23, 2006--Silver Wheaton Corp. (TSX:SLW - News; AMEX:SLW - News) is pleased to announce that it has agreed to purchase 4.75 million ounces of silver per year, for a period of 20 years, from Glencore International AG, equivalent to the production from their Yauliyacu mining operations in Peru. With this acquisition, Silver Wheaton is expected to have annual silver sales of over 15 million ounces in 2006, increasing to 20 million ounces by 2009 and thereafter.

Silver Wheaton will pay an upfront payment of US$285 million, comprised of US$245 million in cash and a US$40 million promissory note, and US$3.90 per ounce of silver delivered under the contract (subject to an inflationary adjustment after three years).

In order to fund the US$245 million cash consideration, Silver Wheaton intends to use cash on hand of US$120 million, together with US$125 million of bank debt. = No Dillution of Shares

They'll Pay $3.90 per Once? - Silver Bullion Closed Today at $ 10.13 Per Once  ;D

The Chart: Awesome!

(http://img.photobucket.com/albums/v11/kcscott/SLWfinal.jpg)

Broke out to new highs on volume - Wish it would have waited 2 days  :P

Oversold? RSI doesn't seem to Move it down

ADX & MACD: The Trend is strong

Looks Good to Me - Now Go Buy it so I can finally win (or at least finish green)

CNES

Why : CNES Entire Network Product Line FCC Approved
Tuesday January 31, 8:37 am ET


VALENCIA, CA--(MARKET WIRE)--Jan 31, 2006 -- ConectiSys Corporation (OTC BB:CNES.OB - News), a developer of automatic meter reading technologies, announced today that the Federal Communications Commission (FCC) has certified and issued Grant IDENTIFIER: SNKHNET50BS8 for its 8C-BaseStation; one of three grants issued representing the entire network equipment for commercialization and sales. View FCC IDENTIFIER: SNKHNET50BS8 (http://www.conectisys.com/H-Net/H-Net_Index/FCC_Approvals/8CH_BaseStation_Grant.pdf)
ADVERTISEMENT


H-Net(TM) Networks and products have been designed exclusively for the Electric Utility Industry. When you combined the above FCC Grants, on a free public band, the results are a unique wireless technology that employs a robust plug and play machine to machine, neuron driven data encrypted commercial communicator ready for commercial release and sales in the US, Canada and South America.



2) Big rumor of big contract by on or after March 15 with a big California company, got an email with this link..

http://www.sce.com/PowerandEnvironment/ami/


3) CNES chart just crossed the Golden Cross see chart below:

//http://stockcharts.com/h-sc/ui?s=cnes




(//)

DYMTF  Dynamotive for me.  Had breakout type volume this week with a news release imminent. (Rumor that I will buy).  Supposedly this deal involves Mitsubishi Heavy industries.  Besides that the alternative energy sector has been doing quite well lately.. Also last week they were certified by the EPC which is an imp. step in legal and regulatory recognition of Biooil. I know some might question this pick with the run it has had the last few days buy I believe it will continue into next week.  That volume is telling me to hold on tight just a while longer.   

Quote from: Ramsburg on February 27, 2006, 02:50:56 PM
Stock Picking Contest (4th Edition - From 6/March/2006 to 10/Apr/2006)

To Submit your Stock Pick, reply to this Topic following the Standard Layout:

1)   Stock Pick
(Ticker & Name of the Company)

2)   Reason behind this pick
(a Text with at least 50 words, featuring the reasons of your stock pick)

3)   Stock Chart
(Click in additional options, browse for your chart file GIF/JPG/PNG and add it to your post, if you don't have a Charting software, we suggest you copy a chart from www.stockcharts.com)

Important: Do not use this thread to another purpose rather than submitting your stock pick. For organizational purposes, any reply that is not a stock pick will be deleted.

;D :)

NICH: Nitches

I like the company for the following reasons:

1. Microcap, profitable co.

2. Undervalued

3. Davids Pick

4. Near 52 week high

5. Comes strongly on my mock random filter ;)

6. I like the sector and brand name of Dockers for which the Co. has supply license.

The company sells women's clothing wholesale to retailers such as Kohl's Corp. and Stein Mart Inc., in October acquired a remaining 72 percent stake of lingerie company Designer Intimates Inc. In the first quarter, which ended Nov. 30, new business from Designer Intimates contributed $6.4 million to Nitches sales.

Nitches swung to a profit of $520,000, or 42 cents per share, from the year-ago quarter's loss of $12,000, or 1 cent per share. Sales jumped to $14.7 million from $6.3 million a year earlier.

I will buy 10% of my portfolio in this pick, at Monday Open.

Goodluck all.

:)

     1. my pick is PTII.OB, Patch International Inc.

     2. Junior oil/gas with outstanding background:

         - float only 3 M, outstanding shares 5 M....
         - they have money, no need for dilution, no PP..!!!
         - recent start of Oil-sands Consortium in Alberta, they will start APEC...!
         - they will present in NY on Mar 8, small cap investors meeting....
         - talks in progress in N. Africa ( incl. Libya ), and Bolivia
         - excellent management, "they will have a lot of news in 2006".....
         - oil-sands will replace OPEC...
         - PTII is almost at 52 wks high, but in my opinion will go much higher after Mar 8...



I do not know how to post the chart on this board, so I will just incl. two web sites where you can see the charts:

http://stockcharts.com/h-sc/ui

http://pro.investortoolbox.com/oit/charts/Corporate_Snapshot.asp?Timespan=130&Symbol=PTII&cpf=undefined


PTII


         

pick i like is
RDCM

Reasons
profitable again in last quarter
strong chart
just bounced at 10 day MA
52 high
good vol
low float

http://stockcharts.com/h-sc/ui?s=rdcm

good luck ppl

My pick is PPHM

Spring is often the time when biotechs shine and I like PPHM's technical setup. On the long term chart posted below, I see a similar setup now to 3 years ago, when PPHM went from a swing low of $.46 to a swing high of $2.12 in two months. The volume in Feb-Mar 2006 hadn't been seen since May-Jun 2003. On the short-term chart, PPHM is consolidating in a big flag formation. Friday's close near the low end of the channel means I get a good entry price in this contest, and entry point is an important factor in a one-month contest.

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biotherapeutics for the treatment of cancer, viruses, and other diseases using targeted antibodies. The company's products portfolio includes Cotara for brain cancer, which is in Phase II/III registration trial, and Tarvacin, an anti-phospholipid therapy agent for the treatment of solid tumors and chronic hepatitis C virus infection.

1)   Stock Pick
Ticker YMI 
Company: YM BioSciences

2)   Reason behind this pick
This company has a good pipeline in the drug research. And has 17 million cash, and just 210 millions market cap. I am looking for a breakout. We have got an ascending triangle with strong volume a matter of time we break 6 the chart is ready to rock. It seems this company is not on the radar yet and so well known.

YM BioSciences, Inc., a development stage biopharmaceutical company, engages in the research and development of products primarily for the treatment of cancer. Its product candidates in the clinical stage of development include Tesmilifene, Nimotuzumab, AeroLEF, Norelin, and Radiotheracim. Tesmilifene, which is in phase III clinical trial, is a small molecule chemopotentiator for the treatment of metastatic and recurrent breast cancer. Nimotuzumab, which is in phase II clinical trial, is an antiepidermal growth factor humanized monoclonal antibody for the treatment of epithelial cancers. AeroLEF, which is in phase II clinical trials, is a proprietary formulation of both free and liposome-encapsulated fentanyl administered by pulmonary inhalation, is being developed for the treatment of severe and moderate acute pain and cancer pain. Norelin is a phase II clinical trial product for the treatment of sex-hormone dependent cancers. Radiotheracim is a radiolabelled humanized monoclonal antibody, targeting the epidermal growth factor receptor, and is being developed for the treatment of brain cancers. The company also has a portfolio of preclinical compounds shown to act as chemopotentiators while protecting normal cells. YM BioSciences has a collaborative agreement with Sanofi-Aventis to investigate the effect of combining tesmilifene and docetaxel for the treatment of women with rapidly progressing metastatic breast cancer. The company was founded in 1994 and is headquartered in Mississauga, Canada.

3)   Chart

1) My Pick: UIS     Unisys Corporation

Unisys Corporation provides information technology (IT) services and solutions to businesses and governments worldwide.

2) Reasons: Strong ascending trendline since lows of Oct/05. Three upper gaps in chart at 6.72, 9.40 and 11.45 - the 6.72 gap was filled just at end of January. Resistance to be overcome in the 7.00 range but after that it is clear sailing all the way to the 9.40 gap. The 200 day moving average is flattening out and Macd and DMI are moderately bullish.
Lets go for the gaps!

3) Charts:

1) CRAY
2) My pick is CRAY because I have lost more money on this stock than any other. I fell in love with it a couple of years ago, and henceforth it fell for me. I mean fell. Anyway lesson learnt. Cray is in a turn around mode as we all know. Tech is presently hot. They make very fast computers with huge capacity. These computers are in greater demand, but the market is very competitive, so cost is a major aspect. I'm hoping for a run to $2.75 an then to fill the gap for a win in this contest. I took half a position in this on friday, I hope CRAY didn't notice. Good luck to all!
3)

My pick is EZM

Reasons behind it:

1. Strong ER was just reported.

EuroZinc Mining Corporation ("EuroZinc" or "the Company") today announced financial results for the fourth quarter and year ending December 31, 2005. Colin K. Benner, Vice Chairman and CEO of EuroZinc commented that, "The investment in Neves-Corvo has been significant for EuroZinc. In the 18 months the Company has owned the Neves-Corvo mine we have repaid almost the entire amount of the acquisition debt, all monies borrowed to acquire the price participation rights and are now accumulating cash. The mine operated in 2005 at production levels beyond what was believed achievable in our due diligence. The operating costs in the mine have remained constant despite inflationary pressures, and the robust copper price has made an extraordinary contribution to our balance sheet, as it has to others in the copper business. The timeliness of the acquisition of Neves-Corvo and the quality of the asset has exceeded the expectations of many. We believe the continued strong copper market, and the addition of zinc production in the near term in a strong zinc market bodes well for the future of the Company and for its shareholders."

Highlights for 2005 and Fourth Quarter

- Achieved record revenue of $314.9 million on sales of 203.7 million pounds of copper for the year and $97.5 million on sales of 48.1 million pounds for the fourth quarter;

- Achieved record net earnings of $88.3 million or US$0.17 (Cdn$0.20) per share for the year and $27.8 million or US$0.05 (Cdn$0.06) for the fourth quarter;

- Generated cash flow from operations, before working capital changes, of $131.4 million or US$0.25 (Cdn$0.30) per share for the year and US$0.09 (Cdn$0.10) for the fourth quarter;

- Initiated an aggressive $10 million exploration program in Portugal;

- Repaid $86.3 million of debt in 2005;

- Strengthened the balance sheet by reducing the net debt to equity ratio to 7% at the 2005 year end from 73% at the beginning of the year;

- Purchased the balance of the vendors' price participation rights in 2005 and repaid the related loan in eight months;

- Listed on the American Stock Exchange.

"We are both pleased and proud of our first full year of work as a new team in Portugal and in EuroZinc," said Joao Carrelo, Managing Director of Somincor, EuroZinc's wholly owned subsidiary that owns the Neves-Corvo mine. Mr. Carrelo added, "This was our first full year as a mine operating entity in Portugal, managing Europe's second largest copper mine. The management and employees of Neves-Corvo achieved a 14 percent improvement, year over year, in tonnes mined and an 8 percent improvement in tonnes milled, and did so with no additional manpower, equipment or change in the working schedules."

2. Zinc price will be going up continuously.

MY pick Is MANU
Manugistics Group, Inc. (Manugistics) is a provider of supply chain, demand and revenue management software products and services. The Company's solutions are configured sets of its software products that address the specific demand and supply chain business processes and revenue management practices that its clients want to improve. These solutions may also include consulting, implementation, training and client support services. Manugistics solutions are built on and rely on its internal WebWORKS platform. WebWORKS is based on the Java 2 Platform and Java2EE industry standards. The solution sets the Company offers are Demand Management and Pricing, Supply Management, Transportation and Logistics, Collaboration and Visibility, Contract Materials Resource Planning & Maintenance, Repair and Overhaul, Performance Management and Revenue Management. The Company markets its solutions to companies throughout North, South and Central America, Europe and the Asia-Pacific region.
Company recently introduced Supply chain tune up program.Company that use this approach will see a 5-10% improvement in forecast accuracy and 1-5% in supply chain costs
company actually missed the earnings reported on 1/6/2006 yet the price went up since than.
company announced that they will reduce head count in America and increase head count in India reducing development cost by 2-3 million /qtr.Signed a deal with SOMERFIELD(UK supermarket chain with1224 stores).Started working with IBM to develop innovative tech.for IBM's websphere e-business platform.

Technically :
   Rsi went from 48 to 62 in 12 months , Money flow increased in the same time period .Broke the consolidation chanel now breaking the ascending triangle.

My Pick is---LOOK---Looksmart LTD.

  Chart is looking great!! Looks ready to break the 5.00 mark soon and when it does expect quick movement up. Looking at the chart you see an ascending triangle forming, considered a very bullish formation. Timeline for resistance break should be 1-3 weeks.

•  Stock Pick:
AVNX Avanex Corp.

•  Stock Profile:
Avanex is a leading global provider of Intelligent Photonic Solutions. Avanex meets the needs of fiber optic communication networks by enabling greater capacity, longer distance transmission, improved connectivity, higher speeds and lower cost.

These solutions enable or enhance optical wavelength multiplexing, dispersion compensation, switching and routing, transmission, amplification, and network managed subsystems.

Headquartered in Fremont, CA, Avanex maintains facilities in Elmira, NY; Nozay, France; San Donato, Italy; and Shanghai, China. The facilities are home to Avanex's Centers of Excellence for specialized research. A world-class manufacturing operation resides in Bangkok, Thailand.

•  Reason behind this pick
AVNX has had a nice spike up in the past 3 days due to some good PR this past week
02/28: Announced the release of a hot-pluggable EDFA (enable simple field upgrades or healing stressed links; it significantly reduces the cost, development time, management and complexity of adding amplification to terminal equipment)
03/01: Announced the introduction of the 1901FBF PowerBragg(TM) Supervisory Channel Filter for Fiber to the Home (FTTH) applications (allows automatic and accurate identification of network faults, whichs enables faster network recovery and the prompt restoration of subscriber services)
03/02: Announced the availability of an industry leading optical performance monitoring (OPM) product portfolio (provides a one-stop solution for OEM and carrier customer optical performance monitoring needs)
03/03: Announced the introduction of its SD10-DP and SD40-DP Lithium Niobate modulators for the Differential Quadrature Phase Shift Keying (DQPSK) modulation format (an ideal format for ultra-long-haul and submarine transmission)

This is all a little bit gibrish for me too, but it all means that they are finally coming out with products that are going to generate profit for the company.
Analysts growth estimates are as follow:
Current Qtr.    61.5%
Next Qtr.        72.7%
This Year        46.9%
Next Year     126.9%

I think AVNX will show a good short term increase

•  Stock Chart

1) GNBT --- GENEREX BIOTECH CORP

2) Business summary:
Generex Biotechnology Corporation engages in the research and development of drug delivery systems and technology. It develops a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. The company's primary product, Oral-lyn is an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes. It also develops Gluco-gyn, a formulated glucose spray used for the treatment of hypoglycemia in people with diabetes, as well as morphine and fentanyl by oral formulation and injection for the treatment of moderate to severe breakthrough and postoperative pain. In addition, the company develops technology for the oral administration of molecule drugs, including proteins, peptides, monoclonal antibodies, hormones, and vaccines. It also engages in the research and development of technologies and immunomedicines for the treatment of malignant, infectious, autoimmune, and allergic diseases.

Its another bird flu momentum play , unfortunately. Altho the company has other products in the pipeline. the Company's flagship product, Generex Oral-lyn™, is the first application for RapidMist and is currently in late stage clinical trials around the world. It recently had good news:
Generex Biotechnology Completes Positive Pre-NDS Meeting With Health Canada for Generex Oral-lyn(TM) http://biz.yahoo.com/iw/060303/0111920.html

Also ,they have been developing an avian-flu vaccine candidate based on its Antigen Express technology. The company presented at the two-day Bird Flu Summit, a conference on the threat of an international pandemic featuring public- and private-sector speakers last week. GNBT and BCRX were 2 major players in the conference.

Last week the company received 11 million from warrant exercises, but the dilution didnt bring down the stock much . on the other hand, the receipt of these funds has put the Company's cash-on-hand at more than $31 million, its strongest cash position in more than four years. I expect any positive PR or bird flu news would push the stock up.

3) chart:

Xwg looks prepared for a breakout. I've owned and sold this baby at least 10 times in the past.

My pick - NWD( New Dragon Asia Corp.)
Sector: Consumer Goods, Industry: Processed & Packaged Goods

Company - This company mills, sells and distributes flour and related products to retail and commercial customers throughout China.

In January, NWD agreed to purchase a company that controls a state-owned noodle manufacturing facility in Chengdu, Sichuan Province, for about $3.3 million.The acquisition, in the western region of China, complements the company's presence in eastern and northern China. NWD expects production at this facility to begin in the second quarter of 2006. Also in December, the company acquired Shandong Xinlongya Distribution Co. Ltd.The acquisition is expected to enhance the profitability of the company's export business by $400,000 on a 12-month basis with export sales increasing to 12% in 2006, from 8% in 2005. In April, the company acquired a 10-year lease agreement for plant and machinery utilized for the production of soybean-derived products. The company estimated that this new line of business would contribute at least $5 million to 2005 revenue.

Reasons for the Pick
(1) Solid Costomer base, noodles to Chinese is like breads to American;
(2) Acquisitions position from regional to statewide and increased export sales;
(3) In IBD top lists several weeks;
(4) Recent pullback to fill the gap due to lack of News.
(5) Quarter report in 03/28 should stimulate movements.

SCU  --  STORM CAT ENERGY CORP - American Stock Exchange
http://www.stormcatenergy.com/

SCU has pulled back and testing a trendline under the lows back to November 2005. Technical indicators are still down but many are moving to oversold. SCU has a $32 million budget for drilling, leasehold and geologic work in 2006. Has producing wells in its Powder River Basin properties. LOI to acquire more CBM properties to drill and bring into production. Properties in Alaska and Canada. The Elk Valley project in BC can be very large and important. SCU is producing and selling CBM gas.


(http://bigcharts.marketwatch.com/charts/big.chart?symb=scu&compidx=aaaaa%3A0&ma=5&maval=9&uf=8&lf=268435456&lf2=32&lf3=1024&type=4&size=2&state=11&sid=1656258&style=320&time=7&freq=1&comp=NO%5FSYMBOL%5FCHOSEN&nosettings=1&rand=5224&mocktick=1)

Wow, alot of people aren't reading the rules this time around.

Anyway, my stock pick for this 4th edition will be AOB.

I was thinking about going with a bird flu play, CBMX to be precise, for this contest seeing how its been on fire lately but I'm going to look at AOB as a bird flu hype play.  AOB's product line includes nutritional supplements which are claimed to strengthen the immune system.  They even go as far as to claim that it will help protect a person from contracting bird flu.  I would guess that these are unsubstantiated claims but if it helps move the share price, so be it.

Technically I am hoping for a bounce off of the 50 MA upon which it is currently resting.  I would wait for a confirmation of this before purchasing, but seeing how the contest starts on Monday, I don't have that luxury.


(http://img389.imageshack.us/img389/1531/aob25th.png)

LVLT : Level Three Comm.
I really liked chart it show's cup formed and I'm expecting handle to come.  higher volume than the previous day for the last five day's with MACD crossover on the last trading day of almost 60 million shares for that day. How much more bullish can a chart show?

bizjournals.com
Level 3 subsidiary plans $400M offering
Friday March 3, 1:39 pm ET
Level 3 Communications Inc. plans to raise $400 million in a private offering of senior notes through a subsidiary, Level 3 Financing Inc.
The Broomfield-based telecom company (NASDAQ: LVLT - News) said it will use the proceeds to finance the cash purchase price of WilTel Communications Group LLC and the proposed acquisition of Progress Telecom LLC. Level 3 closed in December on its purchase of WilTel, for which it paid $386 million and 115 million shares of its stock.
  Level 3 in January announced an agreement to buy Progress Telecom for a total of $137 million -- $68.5 million in cash and $68.5 million of unregistered shares of stock. The company expects the deal to close in the second quarter.
Level 3 said the offering to qualified institutional investors should be completed the week of March 14. The offering will be made in two tranches, one of which will mature in 2011 and a second that will mature in 2013. The allocation between the two hasn't been determined yet.

1. Northgate Minerals Corp (NXG)

2. Northgate Minerals is a gold and copper mining and development company with assets in BC, Canada.  This stock has been on a serious bull run and this news came out a couple of weeks ago: Northgate Reports Record Quarterly Earnings and Cash Flow and Announces That its Project Debt Facility Has Been Retired. (http://biz.yahoo.com/bw/060223/20060223006094.html?.v=1)  I don't think we have seen the end to rising gold and copper prices.  Northgate's assets make it well positioned to continue it's record earnings. >:D

3.  Technically, the stock has shown increasing volume recently and is approaching it's all time high price of $2.58.  Although not perfect technically, we also have something of a cup and handle formation with volume following the shape of the cup as should happen.

* MPH's cash and cash equivalents... $13,756,000 at January 4, 2006.
* Their Burn Rate is on average $2.5 mil Cdn or $2.1 mil US/qtr.
* Phase 2 and Phase 3 trials are being designed in very close consultation with the FDA to ensure the strictest guidelines are adhered to.
* MPH Currently holds 15 Patents and 17 more are pending.
* MPH was granted "Fast Track Status" on Sept.5/05 for it's Cardioprotective Lead Drug MC-1.
* MPH is using a unique intravenous MC-1 formulation in it's Ph2 and Ph3 trials as necessary for the most acute cases to administer the drug in the fastest means possible to ensure the quickest absorbtion rate by the body.
MC-1 is being tested for it's affects on:
~CABG - Coronary Artery Bypass Graft Surgery
~ACS - Acute Coronary Syndrome
~AMI - Acute Myocardial Infarction (heart attacks)
~Stroke as well as Angioplasty

MC-4232 is being tested for it's affects on:
~Hypertension - (Abnormally High Blood Pressure)
~Diabetes

MC-4262 is being tested for it's affects on Metabolic Syndrom.

MC-45308 is being tested for it's affects on Thrombosis (Clots in blood vessels).

MC-5422 is being tested for it's affects on Ischemic Reperfusion.

****MPH's drug Candidate MC-45308 in preclinical research is considered a Breakthough in preventing blood clots as it has demonstrated both Anti-platelet and Anti-coagulant effects...

Dr Friesen stated "A drug of this nature currently is non existent within the Antithrombotic marketplace!"

****Sept.14/05 MPH announced positive Ph2 results for their drug MC-4232 in a matched study with MC-1 and the Ace Inhibitor Lisinopril in the treatment of patients with coexisting diabetes and hypertension, and demonstrated it was safe and well tolerated at all dose levels.

Dr Friesen stated "The Matched trial has exceeded our expectations, demonstrating the outstanding clinical benefits of MC-4232!"

****Dec.5/05 MPH announced positive Ph2 results for MC-1 in the MEND-CABG Trial with amazing results such as the 46.9% reduction in non fatal Myocardial Infarction.

Dr. Friesen stated "The strong efficacy signal observed with MC-1 in MEND-CABG, highlighted by the statistically significant reduction in heart attacks, have exceeded our own expectations, and clearly warrants advancing MC-1 into Pivotol Ph3 developement.

They're expecting a TON of news in a very short period of time. Likely by the end of March or April we will have announcements on all of the following:

1) MC-1 Phase3 begins for MEND-CABG and Matched studies for ACS.
2) MC-4232 Phase3 begins.
3) MC-4262 Phase2 begins.
4) MC-45308 Phase1 begins.
5) MC-5422 Pre-Clinical Trials begin.
6) Results of Phase2, MC-1 MEND-CABG, Post Operative 90 day data.
7) Partnership agreement for the Phase3 trials with a Large Pharma.

It's absolutely incredible how everything is coming together at the same time, and most investors are thinking of only one or two potential news releases. Geeeesh. When this thing blows, it'll blow the top off the Biotech Sector Lid. There's just so much on the plate here I can't comprehend how Dr.Friesen and the management team keep it all organized. If there's delays, I understand why. Keep in mind as well that these potential announcements don't even include the rest of the "Behind the Scenes" stuff such as other R&D, Running the day to day business, obtaining new Board members, upcoming Patents not yet recieved but applied for, Biotec Conferences etc....

We're sitting on a Powder Keg and the fuse is lit!!

Medicure has a Great Website...... http://www.medicure.com/

Cheers..... Dead

http://stockcharts.com/def/servlet/Favorites.CServlet?obj=ID871828

My pick: GTE (GlobeTel Communications Corp.)

GTE provides telecommunication services. It  owns SANSWIRE NETWORKS LLC, which  is developing a technology to  provide wireless broadband Network utilizing blimp like airships called Stratellites.
Two months ago, it signed a  $600 Million Contract to install broadband phone services  in  30 Russian Cities. The share price reached around $4.00. Since then, a couple of Motley fool articles as well as  delay in receiving the  $150 million initial payment has caused the  share price to drop. Yesterday, in an update, GTE informed that the closing of the banking transaction is expected to be finalised in the next few days. News of them receiving the initial payment, should boost the confidence of  investors in this so novel technology and I expect the share price to go up to $4 and resume its upward march.
GTE was also Lucas Scott's choice in the first stock picking contest. It got him the first place. Maybe it still has another win left in it!!!

The chart is here: http://stockcharts.com/h-sc/ui?s=gte


Print - Annotate - Send - Linkable Version - Instructions - Report Problems

1) My Pick: MEK  Metretek

2) Reasons: Metretek's PowerSecure Subsidiary receives record 75 million in orders,in the article they talk about their powerSecure team whatever that is, but I'am sure it must be comparable to the Swedish hockey team.The company is involved with the design and construction of electronic generation equipment.Anyway I bought the sucker and I hope it moves out.
Chart shows strong ascending trendline with breakaway gap on high volume. Seems to be ignoring overbought condition. Macd very bullish indication.

3) Chart:

1)My pick: ICCA  - Internet Commerce Corp.

2) Reason: The reason of this pick is very simple;  the growth of the sales in the last quarters
5.000 - 5.100 -  4.400 - 3.500 - 3.700 (all numbers in thousands)
and the relative growth of the earnings in the same periods
$ 0.03 - $0.03 - $0.01 - $(-0.02) - $(-0.03)
in the last quarter Thomas J. Stallings said :"Our team remains focused on solid execution within each segment, committed to serving the needs of customers and dedicated to our 'Growth with Profitability' strategy. With the acquisition of The Kodiak Group, we have heightened our focus on providing a single source for strategic e-commerce initiatives. We are excited by the interest clients are expressing and expect to see continued revenue growth in the second quarter."

3) view the up channel

Hi,

GNBT (GENEREX BIOTECH CORP ) on the Nasdaq is my pick for the following reasons :

* the avian flue has reached france and France can make a lot of media noise
* most scientists agree to say that it is only a matter of "when" not "if" the virus mutates
* media coverage is increasing every day
* Stock price is having a good momentum
* GNBT is about to make some kind of commercial agreement with the US authorities


GL to all

NERX  <-----

NeoRx  Decent chart only has to get to 2.80 to double from here.  Well form Fridays close anyway.

To be very honest i do not know why this is my pick.  The chart is decent but there are so so soooo many nice charts out there it is hard to choose.  In fact, if i even post this as my pick I'll be surprised 3 different tickers have occupied this space.  First, was SPSC, which is a bb stock, so, it's a no go.  AFOP was the next choice and it appears to have broken through topside from a huge huge channel (about 2 years long and a 137% change inside the channel.  But, based on a prior price movement i anticipate that it will consolidate here.  ILE was next but the last week's candle is concerning.  However, it is a right hand bull and I'm pretty sure the pullback is over.  (Right hand bull you haven't heard of it before, it's new, i coined the term sometime last week).  But, the way i see it, you have to find a pick that is likely to double in a month to win this contest because there are a lot of 50-60% gainers out there to choose from so i guess i have to go with NERX.

My pick for this contest is NVTL.

This thing is extremely oversold with some poor news out over the past few weeks.  Lost a good bit of market share but still selling solid products and still competitive and most importantly still making money.  Reasons it's my pick and I'm looking to free up some money to buy:
1) still profitable and competitive in a great industry
2) big deal with Dell puts their wireless cards in all Dell computers
3) extremely oversold and looking for a bounce
4) solid base at around 8.25 w/ strong support as shown with the price by volume bar
5) RSI in strongly oversold territory and MACD bottoming out
6) strong volume at the bottom and some settling out over the past few days
7) little resistance and several gaps to fill before getting back to the 50 dma... ie has some room to maneuver (around 30%) before any major negative bouncebacks

NVTL just needs a little kick to get it jumpstarted and it could see 11 - 14 again.  Hopefully it happens this month  ;D

Here's the chart:

1)   Finisar Corp (NasdaqNM:FNSR)

2)   Turned up on my iwon.com screen as one of the top gainers for the day on fri 3/5/2006  on 10x volume.  Although it gapped up a whole lot I think it has potential as more investors become aware of it.  It spiked Friday because this network-equipment maker posted better-than-expected third-quarter results.  Chart does not look bad either as this might be in stage 1 of the uptrend.  So in this because of the momentum more than anything.

3)   Stock Chart

Pick: CENVEO INC (NYSE) / CVO

Reason:

Cup and handle, has room to run. Strong volume on breakouts - no where to go but up (me thinks). Insider purchasing is always a positive sign (http://finance.yahoo.com/q/it?s=CVO). They also outweigh sales. Sector and industry doing well as of late. Not that I really care but analyst opinion is positive (http://finance.yahoo.com/q/ao?s=CVO). And I believe they will be making a profit rather soon. But, most importantly - chart looks good, trading strong, RSI pos, insiders buying.

Chart:

My pick is NENG. I told everyone that I probably should have picked NENG for the third contest after I picked my other choice (and loser). NENG was up 38.6 % over the third contest window, which would not have one, but would have been good for third. So this time I am going to stick with NENG as I think its got a lot more to run. To understand NENG, start with this ---

CANTON, Mass. & SAN DIEGO--(BUSINESS WIRE)--Jan. 18, 2006--Network Engines, Inc. (NASDAQ: NENG - News), a leading appliance partner for Microsoft security solutions and Websense, Inc. (NASDAQ: WBSN - News), the world's leading provider of employee internet management solutions, today announced the integration of Websense Web Security Suite software with Network Engines NS Series Security Appliances. Websense Web Security Suite is now shipping on the NS6400 and NS8400 security appliances....

AND....

"Mr. Shortell joins Network Engines from Nokia where he was the Senior Vice President, Global Sales and Marketing. During his tenure there, he was credited with developing Nokia's enterprise delivery network of distribution and reseller channels. While responsible for the global sales and marketing of Nokia's Enterprise Businesses Group, he expanded the business from $14 million in 1997 to more than $1 billion in 2004 by building sales and services in the network security, appliance, connectivity and mobility segments."


Now the OEM side is making more money than it was before and they have the NS side ready to start creating income. Shortell is here to make that happen. I personally feel that he will make it happen. The climb to $11.60 in 03 was pretty fast and steady. When one of these NS deals they have in the pipeline goes through, this stock will explode upwards, IMO.

"Everyone was sure it was going to give most of its gains from the 1.88 to 2.44 run, but it did not and on Friday it exploded upwards to a new high of 2.56, closing at 2.55. I started buying at 1.31 a few months back.

Before this week began I thought we would consolidate for one or two more days, get a PR which I thought would be Getronics, and move right up to $2.75. Well we got two PR's not close to the value of the Getronics news IMO, broke first and final resistance and landed at $2.55. With the Hetronics PR , we should move above $3.00 to $3.25

If you look at the chart below, NENG bottoms on its pullbacks and there is typically only a few days before it starts its next run. That pattern repeated itself here and is of note if you are swing trading this stock. If investors take note of that pattern we could see much more explosive moves off our retracements in the future. Simply stated, when we start to move now, we are going to move fast.

I would not want to be sitting on a short right now. One good PR and this stock is up 20-25% in a day form here. Thats what I believe.

From Yahoo MSG Board: "On Friday a buyer was buying everywhere and doing it frantically, almost as though he was on a time schedule, or either his order was so large he had no choice. I'm almost positive he was even taking out the ask occasionally when things slowed down. It makes one wonder how much he is trying to buy and I for one will be curious to see if it continues Monday. I do not think he was taking the ask to short it though, it just appeared as though it was being bought very aggressively.  This buying finally solidified everything we have been hoping would occur as far as the business model being successful. Smart money is being exposed and they apparently like it and feel certain this company is now in turnaround mode. ... I don't think it will be giving up much gains until we move further, unless this smart money is finished buying, my guess is that it has just started. "

Here is the chart:

PTSC - PATRIOT SCIENTIFI

-They have more than 300 patents
-They just make agreement with Fujitsu
- They have agreement with Casio

My pick: EONC

It reported first profitable quarter last October ($0.05 per share) and is expecting to report another one in coming earning release.

Recent news:

eOn Communications Corporation(TM), a global provider of innovative communications solutions, today announced tha its partner 95Teleweb was selected by Microsoft China to provide contact center services for the company's telemarketing and customer contact initiatives. Under terms of the agreement, 95Teleweb will provide these services in support of Microsoft China's efforts to market it products and service its customers in China.

From the chart, it has higher lows and is ranked No.2 based on latest one quarter return  (229%) in the stock universe, just behind NICH.

My stock pick is Nutrition 21 (NXXI).

I like this stock mainly because of the ADX/DMI, my favorite indicator.  It is showing a strong uptrend, and despite the recent pullback from its 50% pop a couple weeks ago, the stock is still bouncing off the 5-day EMA and closing above it.  Also, all the EMA's are in the correct order from the top down (5, 13, 20, 50, 200).  Those are the ones I use, but only the 13 and 20 are shown on this chart.  The stock has been consolidating in a pennant pattern lately, and seems likely to break to the upside.


Leaira

Hi,

My pick is CTCH

Commtouch Software Ltd. (NASDAQ:CTCH - News) is dedicated to protecting and preserving the integrity of the world's most important communications tool -- email. Commtouch has 15 years of experience developing messaging software, and is a global developer and provider of proprietary anti-spam and Zero-Hour virus protection solutions.

1) Business Updates:

   1. Achieved its tenth consecutive quarter of revenue growth in the
      fourth quarter of 2005, and sees this trend continuing in the
      first quarter of 2006.

   2. Expects operational expenses to drop in the first quarter of
      2006 compared to the fourth quarter of 2005.

   3. Has been experiencing a high rate of renewal business,
      especially with its OEM partners, which is a key element to
      continued growth for the company.

   4. Sees strong demand continuing for messaging security products,
      with global interest in the company's products remaining high.
      The company will continue to sign new OEM partners during 2006.

2) TA:

   RSI, MACD, ADX all look positive and doing well now.

  Volume has been accumulated for three months around $1 and
   price will breakout $1.23 .

3) Charts:

Pick:
IFO - Infosonics Corp

This is more of a earnings play, which is scheduled for 3/8.

With that in mind, I checked out the fundamentals of this stock.
Net Sales growth
2004:Q1-18.7mil, Q2-17.7mil, Q3-17.4mil, Q4-18.9mil
2005:Q1-24.0mil, Q2-32.5mil, Q3-54.2mil, Q4-reporting 3/8

EPS growth
2004:Q1-0.06, Q2-0.09, Q3-0.06, Q4-0.02
2005:Q1-0.05, Q2-0.07, Q3-0.13, Q4-reporting 3/8

"Estimates income from continuing operations before provision for income tax for the quarter ended December 31, 2005, to be at least $0.9 million, compared with $0.2 million for the quarter ended December 31, 2004."  "Revenue for the quarter ended December 31, 2005, is estimated to be at least $34.0 million, an increase of 74% as compared with $19.6 million for the quarter ended December 31, 2004."

The stock is currently trading at 4.42-Price/Book, that's a bargain for this kind of growth potential.

On Jan 30th, the company had a private placement for 13.5mil, priced the company at 13.1 and issued warrants for 18.38.  Perhaps, if I was an investor at the time of the announcement, I would be like what the hell...  Since I wasn't, I been monitoring the stock and it has corrected itself to price in the premium paid for the debt issue.  This is actually good for new investors coming in, using the private placement as a benchmark, don't forget institutional/private investors has valued this stock around 13.10 and believe it has potential to hit 18.38.  In many cases when mini caps looks for capital, investors expect and demand risk premium, its expected.

Currently looking at the stock, the stock has been up for 5 straight days.  It's just screaming for a break-out, it had attempted to go lower but it failed twice.  I believe its called a double bottom, but not sure with the terminology.  If earnings is a blowout, who know where this stock will hit, 20? +60%, the competition?  FYI, I added 900 shares to my portfolio.

1.)My pick is CPST!!! >:D

2.)Reason's its my pick:
-Tons of insider buying last week! >:D
-66 million dollars in cash and virtually no debt
-100 million share float
-chart is showing a symMetric triangle
-deals with Wal-mart! all reason I love the stock...

With over 3,000 Capstone MicroTurbines worldwide, Capstone Turbine is the leading provider of microturbine cogeneration systems for clean, continuous energy management, energy conservation and biogas-fueled renewable energy.

I will be smashing my head to the wall by picking the same stock as last time, AERTA  8).
AERTA manufactures and markets composite building materials that can be used as an alternative to traditional wood products for certain applications in the construction industry.

Fundamental reason:
Fundamentally nothing has changed from last time.
The company has been doing very well recently. 2004 their net income was 1.5 millions but so far for 2005 their net income is about 3.4 millions (4 quarter excluded). Recently they announced that  unaudited gross sales for the quarter ended December 31, 2005 were $24 million, up 55% over gross sales of $15.5 million for the quarter ended December 31, 2004.
There was some insider buying late November.

Technical reason:
It is now resting on a 61.8% Fibonacci (see short term chart) and it is little above an old resistance which now becomes a support (see long term chart). So the downside is minimal but with positive news a very likeable upside (positive earnings announcements f.ex...)

1) ISV -  INSITE VISION INC COM

2) They are an inexpensive stock, between $1 and $5 which typically can give large percentage gains in a short period of time.  They have a product which is in great demand (they work with eyes).  They also recently recieved needed funding and are completeing their required studies.  Overall, they are in a position for their stock price to appreciate over the next month.  They have a conference coming at the end of April, and I anticipate some heavy buying on speculation that the conference will present some very good news on their new research

3) Chart

My pick: CNXT (Conexant Systems Inc.)

Reasons: I see CNXT (and JDSU for that matter) making a strong push to $5.00 within 1 month from now...the semiconductor industry is very optimistic about demands for chips from the end-customer the rest of this year and demand has actually grown around 7% from last year this time.

chart is looking bullish too, with RSI steadily pushing to the 70 level and MACD just entering positive territory.

good luck! 

Chart: please see below

My Pick: VION

Reasons:

1) Should bounce off the 200 MA and confirm an uptrend. MACD & RSI going UP ! ;D

2) Financial losses are less and new star analyst.

3) Great setup, looking for the Golden Cross soon. :D

About VION:

ion Pharmaceuticals, Inc., a development stage company, engages in the development of therapeutics for the treatment of cancer. The company has two small molecule anticancer agents, including CLORETAZINETM (VNP40101M) and Triapine, in clinical development; and other small molecules and a drug delivery system, including KS119W and heterocyclic hydrazones in preclinical development. Its lead product candidate CLORETAZINETM (VNP40101M), which is in Phase II single agent trial, is a sulfonylhydrazine alkylating agent for the treatment of relapsed acute myelogenous leukemia. Triapine is a small molecule that inhibits the enzyme ribonucleotide reductase, and prevents the replication of tumor cells by blocking a critical step in DNA synthesis. Triapine is in Phase II combination trial with gemcitabine in pancreatic cancer. KS119 is an additional cytotoxic (cell-damaging) compound from the sulfonylhydrazine class. Heterocyclic hydrazones are anticancer compounds that have demonstrated potent antitumor effects. It also has one product development program, TAPET (Tumor Amplified Protein Expression Therapy), a drug delivery system using modified Salmonella bacteria, which is designed to deliver anticancer agents directly to solid tumors. Vion Pharmaceuticals has a collaboration agreement with the National Cancer Institute for the clinical development of Triapine. The company was incorporated in 1992 and was formerly known as OncoRx, Inc. It changed its name to Vion Pharmaceuticals, Inc. in 1996. Vion Pharmaceuticals is based in New Haven, Connecticut.

CHART:

hi

Quote from: rickjust on August 14, 1973, 03:41:00 AMb][/b]6]                                                                                                                                                                                                                                                                                                                                                                                                                                              hi !!!!!!!!!!!!!!
My pick for this contest is generix biotechnology
the pipe line off products they have got two positives in two weeks .
also they have orlyn dibetic treatments and also the bird flu vaccine which they got ok from us f d a and ok from the canadian re oryln to start soon after some adjustments.
see chart an yahoo .com also the history off the company.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      i don't think anyone has picked it yet! hom is my pick this month.
it has gradually been going higher this past month . with earnings coming up for this company soon and all rumours are that they are going to be good this might get over six and go on from there.
lets hope so.

Home Solutions of America, Inc. provides residential services, including restoration and specialty interior services primarily to residential properties in the Unites States. The company primarily operates in two segments, Restoration Services and Specialty Interior Services. The Restoration Services segment provides indoor air contamination removal, carpet cleaning, air duct cleaning, and fabric protection services for primarily residential properties. The Specialty Interior Services segment manufactures and installs cabinets and countertops. Home Solutions of America also supplies and installs granite materials for kitchens and baths to national home centers, as well as national builders and remodeling companies. The company was incorporated in 1998 and was formerly known as Nextgen Communications Corporation. It changed its name to Home Solutions of America, Inc. in 2002. Home Solutions of America is headquartered in Dallas, Texas.

********* MSG from Ramsburg ***********
Pick not valid (post count <10, no chart)
(rules here (http://www.3stocksonfire.org/1000stockpickingcontest.php))
*************************************

My pick is LPTH

LightPath Techonologies Inc. manufactures proprietary collimator assemblies, GRADIUM glass products and other optical telecommunications products at its headquarters in Albuquerque. The Company's subsidiaries, Horizon Photonics and Geltech, manufacture isolator products utilizing proprietary automation technology in Walnut, California, and precision molded aspheric optics used in the active telecom components market in Orlando, Florida.

This is based purely on the chart. After consolidated for the past few weeks, and boucing off the 50 EMA, both volume and price picked up on Friday.

Volume Indicators 
20 Day Avg Vol  396,209 
Today / 20 Day Avg Vol  ABOVE 
150 Day Avg Vol  164,104 
Today / 150 Day Avg Vol  ABOVE 
Abnormal Volume  NO 
William Volume Accumulation   bullish
Volume Price Trend   bullish
Momentum Indicators 
10 Day Trend   bullish
40 Day Trend   bullish
100 Day Trend   bullish
Stochastics   neutral
RSI   bearish
MACD   bullish
Moving Average Indictors  
15 Day Trend  bullish
45 Day Trend   bullish
100 Day Trend  bullish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE 
Volatility Index Today MEDIUM 
Volatility Index Yesterday LOW
10 Day Volatility DECREASING
20 Day Volatility DECREASING
40 Day Volatility DECREASING
Candle BULLISH

Cheers ;D
Heres to another kick at the can ;)







   


 

1) ICOC – ICO, Inc.

2) ICO, Inc. is a global producer of custom polymer powders and plastic film concentrates. This company has broad international presence with 18 locations in North America, South America, Europe and the Pacific. The demand of their products comes from chemical companies, oil exploration and production companies as well as manufacturers of plastic products. ICO's sales are impacted by the change in resin prices (raw material prices). If the price of resin goes up, the market prices of their products generally move up.

During the fiscal year 2005 revenues increased 15.2% and operating income rose 57.3% compared to 2004. On February 8, 2006 ICO released their first quarter report for 2006. Operating income increased from $2.8 million to $5.0 million, a 128% increased compared to the same quarter a year earlier. The company also reported net income of $0.11 per share (fully diluted) two cents more than the previous quarter.

A remarkable note has been the large amount of insider buying at ICO last year.

3) The stock rose to a multi-year high back on 02/06/06 when it hit $4.39 on higher than normal volume. Most recently the stock found resistance at $4.38 which has become the new resistance pivot point. All short and long term indicators remain bullish at the current price. A breakout is very possible if the stock is able to move above $4.39.

Hi. All
I like to pick sunwin (SUWN.OB).

Suwn.ob is in  a strong up trend, while consolidating in the last few days. It was rising too fast a week ago, so that it needs some rest.

Fundamentally, it just launch the subsidiary in the US to sell Stevia, as a dietary supplement. In the U.S. there would be a big demand for Stevia, because U.S. has millions of patients with dibetes.

The chart is at
http://stockcharts.com/h-sc/ui?s=%20suwn

Palm. they have  a split coming next month and since they have announced been doing very well   >:D >:D. and as you see the have a nice up trend going.

My pick for the contest is Globetel Communications (GTE):

Globetel, which we all know was a previous 3SOF stock picking contest winner (nice one Lucas ;)) has shown a couple of major spikes in the last couple months, based on expectations regarding their $600m Russian WiMax deal.  Every thime it has spiked up it has gotten beaten down again, mainly as a result of uncertainties surrounding the reality of this deal.  On Friday they announced that it would be delayed one more time (bad) but for a matter of days while the financing gets finalised.  An announcement about the first payment is due this week, and I think this will finally silence the doubters.  They also recently announced a flight test of their Sanswire II stratellite, which was much of the cause of the original runup - this has almost been overshadowed by the russian deal, but I think we will see more announcements about Sanswire - GTE looks ready to rip.

Technically, GTE has validated its ascending trendline several times, and looks set to break out of a symmetrical triangle formation.  MACD and RSI are both ticking up, and we should see heavy trading this week,  with a break to new highs above $4.50 when the announcement is made.  Of course, this is no sure thing, but there is a huge amount of expectation running on this deal, and a failure to produce the goods would kill the stock.  GTE knows it, and I don't believe they would have made the kinds of statements they have unless they were certain this was going through.  I am looking for a $6 target on this one this month - well, we'll see.

LNUX  VA Software Corporation

LNUX has been up big recently after reporting a profitable quarter on Feb 21.  What is bothersome is that the stock was up big on heavy volume the days leading up to earnings.  However, since it peaked at 4.27, it has pulled back to the 38% retracement level.  The stock looks to be consolidating recently on lower volume, but I expect it to breakout again and go to even higher levels.

Profile:
VA Software Corporation, through its subsidiaries, engages in the development, marketing, and support of a software application, known as SourceForge Enterprise Edition in the United States. SourceForge is a proprietary, Web-based software application designed for corporate and public-sector information technology (IT) professionals and software engineering organizations, which combines software development and collaboration tools to track, measure, and report on software project activity.

TXCC - TRANSWITCH CP (NasdaqNM)

I`ll choose TXCC this time !
TXCC used to follow FNSR in the past, as far as I remember !
It was a good sign ( FNSR was up 40 % on friday) !
The semiconductor industry is very optimistic right now !


TranSwitch Corporation, along with its subsidiaries, engages in the design, development,marketing, and support of integrated digital and mixed-signal semiconductor devices for the telecommunications and data communications markets. It offers SONET/SDH products that provide a direct interface for fiber optic transmission in North America, Europe, and Asia. These SONET/SDH products are used to build access equipment, add/drop multiplexers, digital cross-connects, and other telecommunication and data communications equipment, as well as applied in customer premise equipment, such as routers and hubs, and in central offices to add integrated fiber optic transmission capability to telephone switches.

The company was incorporated in 1988 and is headquartered in Shelton, Connecticut.

My pick for this edition of the contest is Alliance Fiber Optic Products Inc.-AFOP.

AFOP is testing new 52 week highs, other companies in this sector are hot right now FNSR,JDSU and AVNX among others are leading the way. The chart looks good with a nice year long cup and handle forming. I expect some consolidation after the recent gains and hope to see 2$ soon.

Alliance Fiber Optic Products, Inc. (AFOP) engages in the design, manufacture, and marketing of fiber optic components for communications equipment manufacturers in the United States and Asia Pacific. The company offers a range of products, including interconnect devices that are used to connect optical fibers and components; couplers and splitters, which are used to divide and combine optical power; and dense wavelength division multiplexing (DWDM) devices that separate and combine multiple specific wavelengths. It also provides wavelength management solutions, which comprise WDM and DWDM components and modules that utilize thin film filter technologies to separate optical signals. In addition, AFOP offers optical devices, which consists of optical depolarizer that reduces the degree of polarization of a light source; automatic variable optical attenuator, which controls the amount of power in an optical fiber; and switchable optical drop/add module that inserts or extracts specific wavelengths in a DWDM system. The company's products are deployed by customers in long-haul networks, metropolitan networks, last mile access networks, and enterprise networks. AFOP was founded in 1995 and is headquartered in Sunnyvale, California.

Stock Pick: CEGE (Cell Genesys)

Reason: According to a long-term chart, it has been breaking out of a downtrend line on strong volume lately, and all other indicators are pointing upward.  It also looks like it wants to break out of the shorter-term uptrending channel.  It's also breaking out nicely from the highs reached last July and December.


Jeff

DSCO   Discovery Labs, Inc.

Received "fast track" designation from the FDA for "Surfaxin" to treat chronic lung disease in premature infants.  April approval pending.

DSCO has also acquired a manufacturing facility and brought on 2 new executives with experience in pediatrics, respiratory therapy, and, pulmonology.

Trials also pending for adults and other uses.  Pending approval in Europe.